Last reviewed · How we verify

NCT05903573

Training Response Artificial Intelligence Network (TRAIN)

Recruiting now NA Last updated 4 December 2025
What this trial tests

NA trial testing Cognitive Training in Amnestic Mild Cognitive Impairment in 75 participants. Currently enrolling.

Timeline
9 October 2023
Primary endpoint
30 April 2028
30 April 2028

Quick facts

Lead sponsorUniversity of Florida
PhaseNA
StatusRecruiting now
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingquadruple
Primary purposetreatment
Enrollment75
Start date9 October 2023
Primary completion30 April 2028
Estimated completion30 April 2028
Sites1 location across United States

Drugs / interventions tested

Conditions studied

Sponsor

University of Florida

Who can join

Adults 55 to 100, any sex, with Amnestic Mild Cognitive Impairment. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study will train a machine learning tool to predict response to a cognitive training intervention using baseline brain MRI sequences from older adults with amnestic mild cognitive impairment.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Cognitive Training

Trials testing the same drug.

Other recruiting trials for Amnestic Mild Cognitive Impairment

Currently open trials in the same condition.

Other University of Florida trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05903573.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing